Elastin Biosciences Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Early Stage VC
  • (Cancelled)

  • Investors
  • 1

Elastin Biosciences General Information

Description

Developer of drug combinations technology intended to inhibit elastin degradation and foster its deposition. The company has identified three novel drug combinations to treat elastin-deficiency-related diseases and promote healthy longevity, enabling the healthcare sector to identify effective and safe drug combinations.

Contact Information

Website
www.elastin.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 167-169 Great Portland Street
  • 5th Floor
  • London W1W 5PF
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 167-169 Great Portland Street
  • 5th Floor
  • London W1W 5PF
  • England, United Kingdom

Elastin Biosciences Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elastin Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 01-Sep-2023 Cancelled Pre-Clinical Trials
3. Seed Round 01-Sep-2023 Completed Pre-Clinical Trials
2. Accelerator/Incubator Completed Pre-Clinical Trials
1. Spin-Off 01-Sep-2023 Completed Pre-Clinical Trials
To view Elastin Biosciences’s complete valuation and funding history, request access »

Elastin Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elastin Biosciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Frame Shift Bio-Incubator Accelerator/Incubator
To view Elastin Biosciences’s complete investors history, request access »

Elastin Biosciences FAQs

  • When was Elastin Biosciences founded?

    Elastin Biosciences was founded in 2023.

  • Where is Elastin Biosciences headquartered?

    Elastin Biosciences is headquartered in London, United Kingdom.

  • What is the size of Elastin Biosciences?

    Elastin Biosciences has 2 total employees.

  • What industry is Elastin Biosciences in?

    Elastin Biosciences’s primary industry is Drug Discovery.

  • Is Elastin Biosciences a private or public company?

    Elastin Biosciences is a Private company.

  • What is Elastin Biosciences’s current revenue?

    The current revenue for Elastin Biosciences is .

  • How much funding has Elastin Biosciences raised over time?

    Elastin Biosciences has raised $2.5M.

  • Who are Elastin Biosciences’s investors?

    Frame Shift Bio-Incubator has invested in Elastin Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process